ARCHIVES

In Brief: DeVita, FDA Chief Help Kill California Bill Legalizing Laetrile Wit committee Testimony

This article is from The Cancer Letter archive.

Vol. 03 No. 34 | August 26, 1977

Download PDF Visit The Full Archive

Related Articles

President Accepts Rauscher Resignation

October 1, 1976

Includes May Business & Regulatory Report (8-page issue).

June 6, 2003

NCI Seeks Changes In CIS Funding Plan With Next Recompetition

April 24, 1987

Cancer Drugs Initiatives To Shorten approval Times, Ensure Post-Marketing Studies, FDA Official Says

April 26, 1996

OMB Backs Down, Releases New Construction Funds After Ruling They Are “Alteration, Renovation”

December 13, 1974

Phase III Alimta Trial Fails To Extend Progression-Free Survival Without Grade 4 Adverse Events

June 28, 2013